Ali Hassan Hamed

Gynecologic Oncology Group

Papers

1

Total Citations

19

H-Index

1

About

Dr. Ali Hassan Hamed is a pioneering gynecologic oncologist whose work centers on fertility-sparing surgical innovations for advanced cervical cancer. His landmark 2012 case report introduced a groundbreaking approach: combining neoadjuvant chemotherapy with simultaneous robotic radical trachelectomy and tubal sterilization reversal for stage IB2 cervical cancer. This procedure, cited 19 times, demonstrated that patients with bulky tumors could preserve fertility through a minimally invasive, multi-step strategy—challenging conventional paradigms that often necessitated radical hysterectomy. Dr. Hamed’s contribution lies in proving the technical feasibility and oncologic safety of integrating chemotherapy with robotic microsurgery, offering young women with locally advanced disease a viable path to future childbearing. His work has influenced subsequent protocols in fertility-preserving oncology, bridging the gap between aggressive tumor control and reproductive autonomy. By documenting this complex, single-stage robotic intervention, Dr. Hamed has provided a template for surgical teams worldwide, expanding the boundaries of what is possible in gynecologic cancer care. His research continues to inspire innovations in tailored, patient-centered surgical oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Neoadjuvant Chemotherapy Followed by Simultaneous Robotic Radical Trachelectomy and Reversal of Tubal Sterilization in Stage IB2 Cervical Cancer
19 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Gynecologic Oncology Group

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago